AI assistant
INSMED Inc — Director's Dealing 2025
Mar 5, 2025
30150_dirs_2025-03-05_b911956c-f433-448f-afcb-3d40d847e578.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: INSMED Inc (INSM)
CIK: 0001104506
Period of Report: 2025-03-03
Reporting Person: Lewis William (Director, Chair and CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-03-03 | Common Stock | M | 18750 | $22.76 | Acquired | 352936 | Direct |
| 2025-03-03 | Common Stock | S | 7317 | $76.24 | Disposed | 345619 | Direct |
| 2025-03-03 | Common Stock | S | 758 | $77.75 | Disposed | 344861 | Direct |
| 2025-03-03 | Common Stock | S | 7763 | $78.61 | Disposed | 337098 | Direct |
| 2025-03-03 | Common Stock | S | 2785 | $79.43 | Disposed | 334313 | Direct |
| 2025-03-03 | Common Stock | S | 127 | $80.90 | Disposed | 334186 | Direct |
| 2025-03-03 | Common Stock | M | 6830 | $10.85 | Acquired | 240754 | Indirect |
| 2025-03-03 | Common Stock | S | 2671 | $76.23 | Disposed | 238083 | Indirect |
| 2025-03-03 | Common Stock | S | 1486 | $78.20 | Disposed | 236597 | Indirect |
| 2025-03-03 | Common Stock | S | 2250 | $78.97 | Disposed | 234347 | Indirect |
| 2025-03-03 | Common Stock | S | 377 | $79.73 | Disposed | 233970 | Indirect |
| 2025-03-03 | Common Stock | S | 46 | $80.90 | Disposed | 233924 | Indirect |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-03-03 | Stock Option (right to buy) | $22.76 | M | 18750 | Disposed | 2025-05-21 | Common Stock (18750) | Direct |
| 2025-03-03 | Stock Option (right to buy) | $10.85 | M | 6830 | Disposed | 2026-05-19 | Common Stock (6830) | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 50500 | Indirect |
Footnotes
F1: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
F2: This is the weighted average sales price representing 7,317 shares sold at prices ranging from $75.91 to $76.90 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
F3: This is the weighted average sales price representing 758 shares sold at prices ranging from $77.13 to $78.12 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
F4: This is the weighted average sales price representing 7,763 shares sold at prices ranging from $78.13 to $79.11 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
F5: This is the weighted average sales price representing 2,785 shares sold at prices ranging from $79.14 to $79.91 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
F6: This is the weighted average sales price representing 2,671 shares sold at prices ranging from $75.93 to $76.77 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
F7: This is the weighted average sales price representing 1,486 shares sold at prices ranging from $77.48 to $78.46 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
F8: This is the weighted average sales price representing 2,250 shares sold at prices ranging from $78.49 to $79.42 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
F9: This is the weighted average sales price representing 377 shares sold at prices ranging from $79.53 to $79.90 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
F10: The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable.